The market revenue for helicobacter pylori testing has been adversely affected by the recent COVID-19 outbreak. Other disease testing services have been significantly impacted by the lucrative demand for COVID-19 testing. The incidence and mortality rate of COVID-19 were at their highest during the initial period, and people tended to forego any other medical treatments or diagnostic procedures. Procedures have been postponed due to the risk of infection during invasive Helicobacter Pylori Diagnostics Market testing at point-of-care facilities.
Additionally, because oral or nasal transmission is the most typical method of COVID-19 transmission, non-invasive tests like the urea breath test (UBT) carried the highest risk of COVID-19 infection, which further limited population preference during a pandemic. point-of-care testing services being interrupted.
Read More @ https://cmiinfonest.blogspot.com/2022/11/helicobacter-pylori-diagnostics-market.html
